Iterum Therapeutics plc announced that Mark Chin informed management that he would be resigning as a member of the Board of Directors of the company with effect from December 31, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | +2.68% |
|
+0.44% | -41.62% |
Jun. 21 | Sector Update: Health Care Stocks Gain in Late Afternoon | MT |
Jun. 21 | Sector Update: Health Care | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.62% | 18.54M | |
+18.97% | 44.44B | |
+41.98% | 40.03B | |
-10.06% | 37.68B | |
+31.15% | 31.46B | |
-7.79% | 27.29B | |
+13.32% | 26.29B | |
+43.05% | 13.8B | |
+31.28% | 12.46B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- ITRM Stock
- News Iterum Therapeutics plc
- Iterum Therapeutics plc Announces the Resignation of Mark Chin as Director, Effective December 31, 2023